4,0
1. März 2013
Mitarbeiter (anonym)
Ehemaliger Mitarbeiter
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Strong Pipeline -- received two FDA approvals in less than 1 year for Perjeta and Kadcyla. Company takes the time to celebrate success.
Kontras
There is a lot of work to be done. A local news broadcast advertised hiring 600 positions to bridge that gap.